Maxim Group Stick to Their Buy Rating for Mesoblast Ltd
Meh, if they're shorting right now, they really might get burnt:
Maxim Group analyst Jason McCarthy maintained a Buy rating on Mesoblast (NASDAQ:MESO) Ltd on Thursday, setting a price target of $16, which is approximately 55.49% above the present share price of $10.29.McCarthy expects Mesoblast Ltd to post earnings per share (EPS) of $0.00 for the first quarter of 2021.
The current consensus among 5 TipRanks analysts is for a Hold rating of shares in Mesoblast, with an average price target of $12.7.
The analysts price targets range from a high of $18 to a low of $6.In its latest earnings report, released on 09/30/2020, the company reported a quarterly revenue of $1.31 million and a net profit of -$35.56 million. The company's market cap is $1.21 billion.
According to TipRanks.com, Maxim Group analyst Jason McCarthy is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 78.0% and a 73.50% success rate.
https://www.investing.com/news/maxim-group-stick-to-their-buy-rating-for-mesoblast-ltd-2413142
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results, page-182
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |